Cite
HARVARD Citation
Ioka, T. et al. (n.d.). 132PLiposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metastatic pancreatic cancer (mPAC). Annals of oncology. p. . [Online].